Enquiry/Quote
Lemborexant bulk supplier for pharma manufacturers

Lemborexant Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 5mg, 10 mg

Reference Brands: Dayvigo (USA)

Category: Sleep Disorders

Lemborexant is a dual orexin receptor antagonist used for treating adult patients with insomnia characterized by difficulties with sleep onset and/or sleep maintenance. It works by competitively blocking the wake-promoting orexin receptors (OX1 and OX2), thus reducing the “wake drive” and enabling sleep. Clinical trials have shown improvements in both sleep onset latency and wake-after-sleep-onset, with maintenance of effect over up to 12 months and a favorable tolerability profile. Lemborexant is available in Tablets and strengths such as 5mg, 10 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Lemborexant is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Lemborexant can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Lemborexant is a medication used for the management and treatment of insomnia, a common sleep disorder characterized by difficulty falling asleep or staying asleep. It belongs to the class of medicines known as dual orexin receptor antagonists, which work by blocking the activity of orexin neuropeptides in the brain that promote wakefulness. By reducing these wake signals, lemborexant helps regulate the sleep–wake cycle and supports the initiation and maintenance of sleep.

This medication is considered a valuable option in the treatment of insomnia, particularly in patients who require improved sleep quality and duration. Lemborexant is prescribed under medical supervision, and its use involves careful consideration of dosing, patient condition, and possible interactions with other medications. Healthcare professionals also monitor patients for effectiveness and potential adverse effects during treatment. With its targeted mechanism of action, lemborexant contributes to better sleep management and improved overall functioning in individuals experiencing insomnia and related sleep disturbances.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Lemborexant is used for the treatment of insomnia, particularly in people who have difficulty falling asleep or staying asleep. It helps improve sleep onset and sleep maintenance by reducing wake signals in the brain.

Lemborexant is made from the active pharmaceutical ingredient lemborexant, which belongs to a class of medicines known as orexin receptor antagonists that act on the central nervous system to regulate the sleep–wake cycle.

A widely known trade name of lemborexant is Dayvigo, which is marketed for the treatment of insomnia in several countries.

Lemborexant was originally developed and marketed by the pharmaceutical company Eisai, and it may also be produced or distributed by other companies depending on regional approvals and partnerships.

The generic name is lemborexant.

The most recognized brand name is Dayvigo.

Lemborexant products are manufactured in regulated pharmaceutical facilities in countries such as the United States, Japan, and other regions that follow international pharmaceutical manufacturing standards.

Yes, Lemborexant is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Lemborexant is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Pitolisant Hydrochloride

Strength:
4.45 mg, 17.8 mg

Form: Tablets

Reference Brands: Wakix (USA/EU)

View Details
Zaleplon

Strength:
5 mg, 10 mg

Form: Capsules

Reference Brands: Sonata (USA/EU), Starnoc (EU)

View Details
Ramelteon

Strength:
8 mg

Form: Tablets

Reference Brands: Rozerem (USA)

View Details
Tasimelteon

Strength:
20 mg

Form: Capsules

Reference Brands: Hetlioz (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.